Phospho-Akt Overexpression in Non–Small Cell Lung Cancer Confers Significant Stage-Independent Survival Disadvantage
Odile David(Tulane University), Arnold R. Brody(University of Vermont), Grace K. Dy(Roswell Park Comprehensive Cancer Center), James R. Jett(Pulmonary and Critical Care Associates), Mitchell Friedman(University of North Carolina at Chapel Hill), Janet Hughes(Tulane University), Helena LeBeau(Tulane University)
Cited by 195
Related Papers
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
|New England Journal of Medicine|2021|1.8k
Alzheimer's Disease: X-Ray Spectrometric Evidence of Aluminum Accumulation in Neurofibrillary Tangle-Bearing Neurons
|Science|1980|992
Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|835